nodes	percent_of_prediction	percent_of_DWPC	metapath
Xylometazoline—ADRA1D—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00218	0.00218	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00217	0.00217	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00214	0.00214	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00212	0.00212	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.0021	0.0021	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00209	0.00209	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00209	0.00209	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00206	0.00206	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—AGTR1—focal segmental glomerulosclerosis	0.00203	0.00203	CbGpPWpGaD
Xylometazoline—ADRA1A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00202	0.00202	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00199	0.00199	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—GNAQ—focal segmental glomerulosclerosis	0.00199	0.00199	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00198	0.00198	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00198	0.00198	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00197	0.00197	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00196	0.00196	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00195	0.00195	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00192	0.00192	CbGpPWpGaD
Xylometazoline—ADRA2A—Platelet activation, signaling and aggregation—SERPINE1—focal segmental glomerulosclerosis	0.00191	0.00191	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00191	0.00191	CbGpPWpGaD
Xylometazoline—ADRA2A—Platelet activation, signaling and aggregation—ALB—focal segmental glomerulosclerosis	0.00191	0.00191	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.0019	0.0019	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00189	0.00189	CbGpPWpGaD
Xylometazoline—ADRA2A—Class A/1 (Rhodopsin-like receptors)—AGT—focal segmental glomerulosclerosis	0.00188	0.00188	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00187	0.00187	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00186	0.00186	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00186	0.00186	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00185	0.00185	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00184	0.00184	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00184	0.00184	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00183	0.00183	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00182	0.00182	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00181	0.00181	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.0018	0.0018	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00179	0.00179	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00178	0.00178	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00176	0.00176	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00174	0.00174	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00174	0.00174	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00173	0.00173	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—EDN1—focal segmental glomerulosclerosis	0.00172	0.00172	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00171	0.00171	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00171	0.00171	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00168	0.00168	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00168	0.00168	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00167	0.00167	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00167	0.00167	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00166	0.00166	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00166	0.00166	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00165	0.00165	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00165	0.00165	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00163	0.00163	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.00162	0.00162	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.00161	0.00161	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.0016	0.0016	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.0016	0.0016	CbGpPWpGaD
Xylometazoline—ADRA2B—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.00159	0.00159	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.00157	0.00157	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—FN1—focal segmental glomerulosclerosis	0.00156	0.00156	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00155	0.00155	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00154	0.00154	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.00154	0.00154	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00152	0.00152	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00152	0.00152	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00152	0.00152	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00152	0.00152	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00151	0.00151	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.0015	0.0015	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—TRPC6—focal segmental glomerulosclerosis	0.0015	0.0015	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—AGTR2—focal segmental glomerulosclerosis	0.0015	0.0015	CbGpPWpGaD
Xylometazoline—ADRA2C—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.00148	0.00148	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00148	0.00148	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00147	0.00147	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00146	0.00146	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—FN1—focal segmental glomerulosclerosis	0.00146	0.00146	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00145	0.00145	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.00144	0.00144	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR ligand binding—AGT—focal segmental glomerulosclerosis	0.00143	0.00143	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00142	0.00142	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00142	0.00142	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—COL4A4—focal segmental glomerulosclerosis	0.00141	0.00141	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00141	0.00141	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.0014	0.0014	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00139	0.00139	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00138	0.00138	CbGpPWpGaD
Xylometazoline—HTR1D—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00138	0.00138	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00138	0.00138	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00138	0.00138	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00137	0.00137	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—TRPC6—focal segmental glomerulosclerosis	0.00137	0.00137	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—AGTR2—focal segmental glomerulosclerosis	0.00136	0.00136	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00135	0.00135	CbGpPWpGaD
Xylometazoline—HTR1B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00135	0.00135	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00135	0.00135	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00135	0.00135	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00134	0.00134	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00133	0.00133	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—COL4A1—focal segmental glomerulosclerosis	0.0013	0.0013	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.0013	0.0013	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—ALB—focal segmental glomerulosclerosis	0.00129	0.00129	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00129	0.00129	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00129	0.00129	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00128	0.00128	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00127	0.00127	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—GNAQ—focal segmental glomerulosclerosis	0.00126	0.00126	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00125	0.00125	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00124	0.00124	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00123	0.00123	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00123	0.00123	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—LIPC—focal segmental glomerulosclerosis	0.00122	0.00122	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.00121	0.00121	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—ALB—focal segmental glomerulosclerosis	0.00121	0.00121	CbGpPWpGaD
Xylometazoline—ADRA2A—Platelet activation, signaling and aggregation—TGFB1—focal segmental glomerulosclerosis	0.00121	0.00121	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.0012	0.0012	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—FN1—focal segmental glomerulosclerosis	0.00118	0.00118	CbGpPWpGaD
Xylometazoline—ADRA1D—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00118	0.00118	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00118	0.00118	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.00118	0.00118	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00118	0.00118	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00117	0.00117	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—NOS2—focal segmental glomerulosclerosis	0.00117	0.00117	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00117	0.00117	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00115	0.00115	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—AGTR1—focal segmental glomerulosclerosis	0.00115	0.00115	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—GNAQ—focal segmental glomerulosclerosis	0.00114	0.00114	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00113	0.00113	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00112	0.00112	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—COL4A3—focal segmental glomerulosclerosis	0.0011	0.0011	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00109	0.00109	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—CTGF—focal segmental glomerulosclerosis	0.00108	0.00108	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00107	0.00107	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.00107	0.00107	CbGpPWpGaD
Xylometazoline—ADRA2B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00107	0.00107	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.00106	0.00106	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.00106	0.00106	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00105	0.00105	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.00105	0.00105	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—AGTR1—focal segmental glomerulosclerosis	0.00104	0.00104	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.00103	0.00103	CbGpPWpGaD
Xylometazoline—ADRA2C—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000996	0.000996	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—LIPC—focal segmental glomerulosclerosis	0.000994	0.000994	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000993	0.000993	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000993	0.000993	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000987	0.000987	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000984	0.000984	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—SERPINE1—focal segmental glomerulosclerosis	0.000984	0.000984	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—ALB—focal segmental glomerulosclerosis	0.000982	0.000982	CbGpPWpGaD
Xylometazoline—ADRA1B—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.00098	0.00098	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000977	0.000977	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—EDN1—focal segmental glomerulosclerosis	0.000975	0.000975	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000972	0.000972	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000968	0.000968	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000953	0.000953	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000905	0.000905	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.0009	0.0009	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000892	0.000892	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.00089	0.00089	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000889	0.000889	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—EDN1—focal segmental glomerulosclerosis	0.000885	0.000885	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—CTGF—focal segmental glomerulosclerosis	0.000875	0.000875	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000873	0.000873	CbGpPWpGaD
Xylometazoline—ADRA1A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000871	0.000871	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000868	0.000868	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000865	0.000865	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000863	0.000863	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000847	0.000847	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.00083	0.00083	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00082	0.00082	CbGpPWpGaD
Xylometazoline—ADRA2B—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000819	0.000819	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000817	0.000817	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000813	0.000813	CbGpPWpGaD
Xylometazoline—ADRA2A—GPCR downstream signaling—AGT—focal segmental glomerulosclerosis	0.000809	0.000809	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TRPC6—focal segmental glomerulosclerosis	0.000807	0.000807	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—GNAQ—focal segmental glomerulosclerosis	0.000806	0.000806	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000803	0.000803	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AGTR2—focal segmental glomerulosclerosis	0.000802	0.000802	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000791	0.000791	CbGpPWpGaD
Xylometazoline—ADRA2C—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000765	0.000765	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000763	0.000763	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000759	0.000759	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000747	0.000747	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—LPL—focal segmental glomerulosclerosis	0.000747	0.000747	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000741	0.000741	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.00074	0.00074	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling by GPCR—AGT—focal segmental glomerulosclerosis	0.000735	0.000735	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000726	0.000726	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000725	0.000725	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000701	0.000701	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000689	0.000689	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000684	0.000684	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—GNAQ—focal segmental glomerulosclerosis	0.000674	0.000674	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.00067	0.00067	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000669	0.000669	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000664	0.000664	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000644	0.000644	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—AGT—focal segmental glomerulosclerosis	0.000639	0.000639	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000634	0.000634	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000634	0.000634	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000633	0.000633	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000625	0.000625	CbGpPWpGaD
Xylometazoline—ADRA2A—Hemostasis—TGFB1—focal segmental glomerulosclerosis	0.000621	0.000621	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AGTR1—focal segmental glomerulosclerosis	0.000617	0.000617	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000615	0.000615	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—LPL—focal segmental glomerulosclerosis	0.000607	0.000607	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000592	0.000592	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000585	0.000585	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000582	0.000582	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000572	0.000572	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000569	0.000569	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000563	0.000563	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000557	0.000557	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000546	0.000546	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000534	0.000534	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000529	0.000529	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000526	0.000526	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—EDN1—focal segmental glomerulosclerosis	0.000523	0.000523	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—AGT—focal segmental glomerulosclerosis	0.000519	0.000519	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.000517	0.000517	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—LPL—focal segmental glomerulosclerosis	0.000507	0.000507	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000494	0.000494	CbGpPWpGaD
Xylometazoline—ADRA2C—Metabolism—ALB—focal segmental glomerulosclerosis	0.00049	0.00049	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000487	0.000487	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000486	0.000486	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SPP1—focal segmental glomerulosclerosis	0.00048	0.00048	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000467	0.000467	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.00044	0.00044	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000436	0.000436	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—AGT—focal segmental glomerulosclerosis	0.000434	0.000434	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000432	0.000432	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000427	0.000427	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000411	0.000411	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000404	0.000404	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—FN1—focal segmental glomerulosclerosis	0.000401	0.000401	CbGpPWpGaD
Xylometazoline—ADRA2A—Metabolism—ALB—focal segmental glomerulosclerosis	0.000398	0.000398	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000373	0.000373	CbGpPWpGaD
Xylometazoline—HTR1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000359	0.000359	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000359	0.000359	CbGpPWpGaD
Xylometazoline—HTR1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000352	0.000352	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000337	0.000337	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—SERPINE1—focal segmental glomerulosclerosis	0.000334	0.000334	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000315	0.000315	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.00031	0.00031	CbGpPWpGaD
Xylometazoline—ADRA1D—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000308	0.000308	CbGpPWpGaD
Xylometazoline—ADRA2B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000278	0.000278	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000275	0.000275	CbGpPWpGaD
Xylometazoline—ADRA2C—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000259	0.000259	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—MMP9—focal segmental glomerulosclerosis	0.000256	0.000256	CbGpPWpGaD
Xylometazoline—ADRA1B—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000255	0.000255	CbGpPWpGaD
Xylometazoline—ADRA1A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000227	0.000227	CbGpPWpGaD
Xylometazoline—ADRA2A—Signaling Pathways—TGFB1—focal segmental glomerulosclerosis	0.000211	0.000211	CbGpPWpGaD
